Pre-Diagnosis FEV1 Decline Predicts Lung Transplant Survival

Chronic lung allograft dysfunction remains the primary barrier to long-term survival following lung transplantation, representing a heterogeneous spectrum of immune-mediated graft injury [1, 2, 3]. The condition involves a complex interplay of innate and adaptive immune responses that lead to progressive, often irreversible, tissue remodeling and airway obstruction [4]. While various immunomodulatory strategies such as extracorporeal photopheresis (a procedure where white blood cells are treated with a photosensitizing agent and ultraviolet light to modulate the immune response) and macrolide antibiotics are employed to stabilize graft function, clinical responses remain highly variable among recipients [5, 6]. Current diagnostic criteria focus on a sustained decline in forced expiratory volume in 1 s (the volume of air exhaled during the first second of a forced breath), yet these markers often fail to capture the individual pace of disease progression. Recent data indicate that the rate of forced expiratory volume in 1 s decline among nonsurvivors is significantly higher at -148 milliliters per month compared to -77 milliliters per month in survivors (p = 0.0001) [7]. A new study examines whether the specific trajectory of lung function loss leading up to a formal diagnosis can serve as a reliable predictor of future graft failure and mortality.